Search the web
Sign In
New User? Sign Up
CLLResearch · CLL-Researchand Advocacy
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Real people. Real stories. See how Yahoo! Groups impacts members worldwide.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Drug cross-resistance and therapy-induced resistance in chronic lymp   Message List  
Reply | Forward Message #12385 of 12781 |
Drug cross-resistance and therapy-induced resistance in chronic lymphocytic
leukaemia by an enhanced method of individualised tumour response testing.
Andrew G Bosanquet, Sue M Richards, Rachel Wade, Monica Else, Estella Matutes,
Martin J S Dyer, Saad M B Rassam, Justin Durant, Sheila M Scadding, Steve L
Raper, Claire E Dearden, and Daniel Catovsky
Br J Haematol, June 22, 2009;

Bath Cancer Research, Royal United Hospital, Bath.

Previous results with individualised tumour response testing (ITRT) in vitro in
chronic lymphocytic leukaemia (CLL) have consistently shown good correlation
with patient response and survival. We describe here an improved test and report
its use with samples from the Leukaemia Research Fund CLL4 randomised clinical
trial and previously treated patients. ITRT was performed by the tumour response
to anti-neoplastic compounds (TRAC) assay, a modification of the differential
staining cytotoxicity (DiSC) assay. Improvements included drying drugs into
wells before assay and using the Octospot system to cytocentrifuge eight spots
of cells onto one microscope slide. We successfully tested 765/782 (98%)
cellular blood samples received within 48 h of phlebotomy. Cross-resistance
(Pearson's r > 0.7) in untreated CLL was found between similar drugs.
Mitoxantrone (r = 0.31), cyclophosphamide (r = 0.35) and pentostatin (r = 0.29)
had low cross-resistance with fludarabine. Treatment resulted in increased
resistance to chlorambucil, cyclophosphamide, doxorubicin, mitoxantrone,
corticosteroids, cladribine and fludarabine (P < 0.01) but not to pentostatin.
These results provide further rationale for standard drug combinations such as
fludarabine-mitoxantrone and fludarabine-mitoxantrone-cyclophosphamide and
suggest possible pentostatin salvage in fludarabine-resistant patients. ITRT
results could assist both in determining the best treatment for individual
patients and in the design and rationale of future clinical trials.
PMID: 19552723

.
----------


No virus found in this outgoing message.
Checked by AVG - www.avg.com
Version: 8.5.375 / Virus Database: 270.13.3/2216 - Release Date: 07/03/09
05:53:00


[Non-text portions of this message have been removed]




Sat Jul 4, 2009 12:16 am

calebmishka
Offline Offline
Send Email Send Email

Forward
Message #12385 of 12781 |
Expand Messages Author Sort by Date

Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing. Andrew G...
Andrew Gach
calebmishka
Offline Send Email
Jul 4, 2009
12:09 am
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help